診断用酵素の市場規模、シェア、動向分析レポート：タイプ別（Taq Polymerase、MMLV RT、HIV RT）、用途別（糖尿病、腫瘍、心臓病）、製品タイプ別、地域別、セグメント別予測、2022年～2030年

診断用酵素の市場成長と動向

Grand View Research, Inc.の新しいレポートによると、診断用酵素の世界市場規模は、予測期間中に3.97%のCAGRを記録し、2030年までに62億6000万米ドルに達する見込みです。診断用酵素市場の成長は、病理学に広く応用された診断用酵素の需要の高まりに起因しています。さらに、ウイルス感染の診断技術の進歩が市場成長を促進すると予想されています。

診断用酵素は、酵素活性によってもたらされる高い感度と精度により、広く採用されています。酵素活性は、臨床症状やその他の診断指標よりも早期に発見することが可能です。バイオセンサーは、医療診断、病原体の検出、モニタリングのための潜在的なツールとして普及しつつあります。バイオセンサーは、精度、感度、選択性、そして日常的に使用できる迅速な検出戦略により人気を博しています。酵素の血清レベルの診断は、細胞間成分の血流への放出をもたらす細胞障害の指標として使用されてきました。

呼吸器のウイルス感染症は、ヒトに最も多く見られる疾患の一つであり、COVID-19に代表される新興ウイルスの発生によって引き起こされるものは、公衆衛生上の脅威となっています。そのため、このような流行の発生を食い止め、不必要な抗生物質の使用を防ぐためには、ウイルス性病原体の検出が不可欠です。そのため、新しい診断戦略が主要なプレーヤーによって採用されています。LightMix（Roche Molecular Diagnostics, Switzerland）, AccuPower（Bioneer, Korea）, PowerChek（Kogene Biotech, Korea）, Anyplex（Seegene, Korea）, UltraFast kits（Nanobiosys, Korea）, and DiaPlexQ（SolGent, Korea）は感度 99.03%と高いMERS-CoV RNA検出用市販RT-PCRキットの一部です。

診断用酵素検査の数が増えたことで、その性能に関する多くの論文が発表され、推奨やガイドラインが盛り上がりを見せています。さらに、保険償還経路には明確なガイドラインや体系的な医療技術評価（HTA）が欠如しています。診断用酵素検査に対する支払者の意思決定に影響を与える要因としては、FDAの認可、医師のサポートと臨床ガイドライン、競合他社の保険適用方針、費用/便益分析、HTAの結果、雇用主や支援団体の要求などが挙げられます。

さらに、同市場で事業を展開する主要企業は、幅広い用途に使用できる製品の拡大や上市に注力しています。例えば、2022年3月、メリディアン・バイオサイエンス社は、非侵襲的リキッドバイオプシーに使用できるマスターミックス2種を発売しました。このような画期的な技術の発売により、精製核酸からの従来のqPCRと比較して、性能レベルのより良い分析が可能になります。

診断用酵素市場レポートハイライト

2021年、グルコースオキシダーゼ/グルコースデヒドロゲナーゼ酵素セグメントは、生体内に豊富な酵素が存在することから、市場で圧倒的なシェアを占めている

がんの有病率の増加により、予測期間中、がん領域が最も速い速度で成長すると予測される

研究開発への注力により、2021年には臨床分野が最も高い収益を上げる分野となります。

診断用酵素市場は、市場での地位を維持するために製品の上市と地理的拡大に注力する主要な市場プレイヤーの存在によって変化している

アジア太平洋地域は、製造施設の改善とターゲット人口の存在により、予測期間中に最も速い成長を遂げると予想されます。

目次

第1章 調査手法と範囲

• 市場セグメンテーション
• 調査手法
• 情報調達
  • 購入したデータベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ1：コモディティフローアプローチ
    • アプローチ2：ボトムアップアプローチを使用した国別の市場推定
• 世界市場：CAGR計算
• 調査の仮定
• 二次情報一覧
• 一次情報のリスト
• 目的
• 略語一覧

第2章 エグゼクティブサマリー

• 市場概要

第3章 診断用酵素市場の変数、動向、および範囲

• 診断用酵素市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し- 体外診断（IVD）市場
• 浸透と成長の見通しのマッピング
• 市場力学
• 市場促進要因分析
  • 診断における酵素の需要の増加
  • 病理学における酵素の幅広い応用
  • ウイルス感染症の診断検査の進歩
  • POC検査の需要の増加
• 市場抑制要因分析
  • 酵素ベースの診断検査の高コスト
  • 酵素診断の規制と償還のハードル
• SWOT分析：要因別（政治と法律、経済、技術）
• ポーターのファイブフォース分析

第4章 診断用酵素市場：セグメント分析、タイプ別、2018年から2030年

• 診断用酵素市場：タイプ別の変動分析
  • Taqポリメラーゼ
  • MMLVRT
  • HIV RT
  • ホットスタート Taq Pol
  • 国連
  • RNase阻害剤
  • Bstポリメラーゼ（LAMP酵素）
  • PCRマスターミックス
  • 凍結乾燥ポリメラーゼ
  • T7 RNAポリメラーゼ
  • Cas9酵素
  • 酸性ホスファターゼ
  • アラニンアミノ基転移酵素
  • アルカリホスファターゼ
  • アミラーゼ
  • アンギオテンシン変換酵素
  • アスパラギン酸アミノトランスフェラーゼ
  • コリンエステラーゼ
  • クレアチニンキナーゼ
  • ガンマグルタミルトランスフェラーゼ
  • 乳酸脱水素酵素
  • レニン
  • グルコースオキシダーゼ/グルコースデヒドロゲナーゼ
  • ウレアーゼ
  • 乳酸オキシダーゼ
  • 西洋わさび過酸化物
  • グルタミン酸オキシダーゼ
  • その他

第5章 診断用酵素市場：セグメント分析、用途別、2018年から2030年

• 診断用酵素市場：用途別の変動分析
  • 糖尿病
  • 腫瘍学
  • 心臓病学
  • 感染症
  • 腎臓学
  • 自己免疫疾患
  • その他

第6章 診断用酵素市場：セグメント分析、製品タイプ別、2018年から2030年

• 診断用酵素市場：製品タイプ別の変動分析
  • 分子酵素
  • 臨床酵素

第7章 診断用酵素市場：セグメント分析、地域別、2018年～2030年

• 診断用酵素市場：地域別の変動分析
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
• アジア太平洋地域
  • 日本
  • 中国
  • インド
• 世界のその他の地域
  • ブラジル
  • 南アフリカ

第8章 診断用酵素市場：競合分析

• 最近の動向と影響分析：主要な市場参入企業別
  • アンゾフマトリックス
  • 主要取引と戦略的提携分析
    • 市場拡大
    • 製品の発売
    • 取得
    • パートナーシップとコラボレーション
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2021年
• 公開会社
  • 会社の市況分析
  • ヒートマップ分析
  • 地域ネットワークマップ
  • 競合ダッシュボード分析
    • 市場の差別化要因
• 非公開会社
  • 主要な新興企業のリスト
  • ヒートマップ分析
  • 地域ネットワークマップ

第9章 企業プロファイル

• Takara Bio, Inc.
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Promega Corporation
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Enzo Life Sciences, Inc.
  • 会社概要
  • 製品のベンチマーク
• Merck KGaA
  • 会社概要
    • シグマアルドリッチ株式会社
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Thermo Fisher Scientific, Inc.
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Creative Enzymes
  • 会社概要
  • 製品のベンチマーク
• F. Hoffmann-La Roche Ltd.
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Solis BioDyne
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
• Ampliqon A/S
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ

List of Tables

• TABLE 1 List of Secondary Sources
• TABLE 2 List of Abbreviations
• TABLE 3 Regulatory Framework
• TABLE 4 Global diagnostic enzymes market, by region, 2018 - 2030 (USD Million)
• TABLE 5 Global diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 6 Global diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 7 Global diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 8 North America diagnostic enzymes market, by country, 2018 - 2030 (USD Million)
• TABLE 9 North America diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 10 North America diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 11 North America diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 12 U.S. diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 13 U.S. diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 14 U.S. diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 15 Canada diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 16 Canada diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 17 Canada diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 18 Europe diagnostic enzymes market, 2018 - 2030 (USD Million)
• TABLE 19 Europe diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 20 Europe diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 21 Europe diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 22 UK diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 23 UK diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 24 UK diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 25 Germany diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 26 Germany diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 27 Germany diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 28 France diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 29 France diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 30 France diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 31 Asia Pacific diagnostic enzymes market, 2018 - 2030 (USD Million)
• TABLE 32 Asia Pacific diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 33 Asia Pacific diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 34 Asia Pacific diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 35 Japan diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 36 Japan diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 37 Japan diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 38 China diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 39 China diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 40 China diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 41 India market, by type, 2018 - 2030 (USD Million)
• TABLE 42 India diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 43 India diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 44 Rest of Worlddiagnostic enzymes market, 2018 - 2030 (USD Million)
• TABLE 45 Rest of Worlddiagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 46 Rest of Worlddiagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 47 Rest of Worlddiagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 48 Brazil diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 49 Brazil diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 50 Brazil diagnostic enzymes market, by application, 2018 - 2030 (USD Million)
• TABLE 51 South Africa diagnostic enzymes market, by type, 2018 - 2030 (USD Million)
• TABLE 52 South Africa diagnostic enzymes market, by product type, 2018 - 2030 (USD Million)
• TABLE 53 South Africa diagnostic enzymes market, by application, 2018 - 2030 (USD Million)

List of Figures

• FIG. 1 Diagnostic enzymes market segmentation
• FIG. 2 Market research process
• FIG. 3 Data triangulation techniques
• FIG. 4 Primary research pattern
• FIG. 5 Market research approaches
• FIG. 6 Value-chain-based sizing & forecasting
• FIG. 7 QFD modeling for market share assessment
• FIG. 8 Market formulation & validation
• FIG. 9 Diagnostic enzymes market snapshot
• FIG. 10 Penetration and growth prospect mapping for application, 2021 (USD Million)
• FIG. 11 Market Dynamics
• FIG. 12 Diagnostic enzymes market driver impact
• FIG. 13 Enzymes in the diagnosis of diseases
• FIG. 14 Common applications of enzymes in pathology
• FIG. 15 Diagnostic enzymes market restraint impact
• FIG. 16 Porter's five forces analysis
• FIG. 17 Diagnostic enzymes market: Type outlook and key takeaways
• FIG. 18 Common diagnostic enzymes
• FIG. 19 Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 20 MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 21 HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 22 Evaluation Index of Antibody Modified Hot Start Taq DNA Polymerase
• FIG. 23 Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 24 UNG market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 25 RNase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 26 Bst polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 27 PCR master mix market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 28 Lyophilized polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 29 T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 30 Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 31 Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 32 Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 33 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 34 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 35 Angiotensin-converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 36 Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 37 Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 38 Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 39 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 40 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 41 Renin market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 42 Glucose oxidase/Glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 43 Urease market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 44 Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 45 Horseradish peroxide market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 46 Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 48 Diagnostic enzymes market : Application outlook and key takeaways
• FIG. 49 Diagnostic enzymes market: Application movement analysis
• FIG. 50 Global diabetes prevalence data and forecast (numbers in million)
• FIG. 51 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 52 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 53 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 54 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 55 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 56 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 57 Others market estimates and forecast, 2017-2030, USD Million
• FIG. 58 Diagnostic enzymes market : Application outlook and key takeaways
• FIG. 59 Diagnostic enzymes market: Product type movement analysis
• FIG. 60 Molecular enzymes market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 61 Clinical enzymes market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 62 Diagnostic Enzymes Market: Regional outlook and key takeaways
• FIG. 63 Diagnostic enzyme market: Regional movement analysis
• FIG. 64 North America
• FIG. 65 North America. market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 66 U.S.
• FIG. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 68 Canada
• FIG. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 70 Europe
• FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 72 UK
• FIG. 73 UK market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 74 Germany
• FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 76 France
• FIG. 77 France market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 78 Asia Pacific
• FIG. 79 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 80 Japan
• FIG. 81 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 82 China
• FIG. 83 China. market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 84 India
• FIG. 85 India. market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 86 Rest of World
• FIG. 87 Rest of world market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 88 Brazil
• FIG. 89 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 90 South Africa
• FIG. 91 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• FIG. 92 Ansoff Matrix
• FIG. 93 Strategy mapping
• FIG. 94 Company market share analysis, 2021
• FIG. 95 Company market position analysis
• FIG. 96 Company market position analysis
• FIG. 97 Heat Map Analysis
• FIG. 98 Market differentiators
• FIG. 99 Heat Map Analysis
• FIG. 100 Regional Network Map

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 6.26 billion by 2030, registering a CAGR of 3.97% during the forecast period, according to a new report by Grand View Research, Inc.Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

• In 2021, the glucose oxidase/glucose dehydrogenase enzyme segment held a dominant share in the market owing to the presence of an abundance of enzymes in living organisms

• The oncology segment is projected to grow at the fastest rate during the forecast period owing to the increasing prevalence of cancer among the population

• The clinical segment is the highest revenue-generating segment in 2021 owing to the increased focus on R&D

• The diagnostic enzyme market is witnessing change owing to the presence of key market players focusing on product launches and geographic expansion to maintain their position in the market

• Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the presence of the target population

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Secondary Sources
  • 1.3.3 Primary Research
  • 1.3.4 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.1.2 Approach 2: Country-wise Market Estimation Using Bottom-Up Approach
• 1.7 Global Market: CAGR Calculation
• 1.8 Research Assumptions
• 1.9 List of Secondary Sources
• 1.10 List of Primary Sources
• 1.11 Objectives
  • 1.11.1 Objective 1
  • 1.11.2 Objective 2
• 1.12 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Summary

Chapter 3 Diagnostic Enzymes Market Variables, Trends, & Scope

• 3.1 Diagnostic Enzymes Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (IVD) Market
• 3.2 Penetration and Growth Prospect Mapping
• 3.3 Market Dynamics
• 3.4 Market Driver Analysis
  • 3.4.1 Rise in the demand for enzymes in diagnostics
  • 3.4.2 Wide applications of enzymes in pathology
  • 3.4.3 Advancements in diagnostic testing of viral infections
  • 3.4.4 Increase in the demand for Point-of-Care testing
• 3.5 Market Restraint Analysis
  • 3.5.1 High cost of enzyme-based diagnostic tests
  • 3.5.2 Regulatory & reimbursement hurdles for enzyme diagnostics
• 3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
• 3.7 Porter's Five Forces Analysis

Chapter 4 Diagnostic Enzymes Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1 Diagnostic Enzymes Market: Type Movement Analysis
  • 4.1.1 Taq Polymerase
    • 4.1.1.1 Taq Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.2 MMLV RT
    • 4.1.2.1 MMLV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.3 HIV RT
    • 4.1.3.1 HIV RT Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.4 Hot Start Taq Pol
    • 4.1.4.1 Hot Start Taq Pol Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.5 UNG
    • 4.1.5.1 UNG Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.6 Rnase Inhibitors
    • 4.1.6.1 Rnase Inhibitors Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.7 Bst Polymerase (LAMP Enzyme)
    • 4.1.7.1 Bst Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.8 PCR Master Mix
    • 4.1.8.1 PCR Master Mix Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.9 Lyophilized Polymerase
    • 4.1.9.1 Lyophilized Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.10 T7 RNA Polymerase
    • 4.1.10.1 T7 RNA Polymerase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.11 Cas9 Enzyme
    • 4.1.11.1 Cas9 Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.12 Acid Phosphatase
    • 4.1.12.1 Acid Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.13 Alanine Aminotransferase
    • 4.1.13.1 Alanine Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.14 Alkaline Phosphatase
    • 4.1.14.1 Alkaline Phosphatase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.15 Amylase
    • 4.1.15.1 Amylase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.16 Angiotensin Converting Enzyme
    • 4.1.16.1 Angiotensin Converting Enzyme Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.17 Aspartate Aminotransferase
    • 4.1.17.1 Aspartate Aminotransferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.18 Cholinesterase
    • 4.1.18.1 Cholinesterase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.19 Creatinine Kinase
    • 4.1.19.1 Creatinine Kinase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.20 Gamma Glutamyl Transferase
    • 4.1.20.1 Gamma Glutamyl Transferase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.21 Lactate Dehydrogenase
    • 4.1.21.1 Lactate Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.22 Renin
    • 4.1.22.1 Renin Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.23 Glucose Oxidase/Glucose Dehydrogenase
    • 4.1.23.1 Glucose Oxidase/Glucose Dehydrogenase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.24 Urease
    • 4.1.24.1 Urease Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.25 Lactate Oxidase
    • 4.1.25.1 Lactate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.26 Horseradish Peroxide
    • 4.1.26.1 Horseradish Peroxide Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.27 Glutamate Oxidase
    • 4.1.27.1 Glutamate Oxidase Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.1.28 Others
    • 4.1.28.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Diagnostic Enzymes Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1 Diagnostic Enzymes Market: Application Movement Analysis
  • 5.1.1 Diabetes
    • 5.1.1.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.1.2 Oncology
    • 5.1.2.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.1.3 Cardiology
    • 5.1.3.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.1.4 Infectious Diseases
    • 5.1.4.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.1.5 Nephrology
    • 5.1.5.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.1.6 Autoimmune Diseases
    • 5.1.6.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.1.7 Others
    • 5.1.7.1 Others Market Estimates And Forecast, 2017-2030, USD Million

Chapter 6 Diagnostic Enzymes Market - Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

• 6.1 Diagnostic Enzymes Market: Product Type Movement Analysis
  • 6.1.1 Molecular Enzymes
    • 6.1.1.1 Molecular Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.1.2 Clinical Enzymes
    • 6.1.2.1 Clinical Enzymes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Diagnostic Enzymes Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

• 7.1 Diagnostic Enzymes Market: Regional Movement Analysis
• 7.2 North America
  • 7.2.1 North America Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.2.2 U.S.
    • 7.2.2.1 U.S. Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.2.3 Canada
    • 7.2.3.1 Canada Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
• 7.3 Europe
  • 7.3.1 Europe Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.3.2 UK
    • 7.3.2.1 UK Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.3.3 Germany
    • 7.3.3.1 Germany Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.3.4 France
    • 7.3.4.1 France Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
• 7.4 Asia Pacific
  • 7.4.1 Asia Pacific Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.4.2 Japan
    • 7.4.2.1 Japan Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.4.3 China
    • 7.4.3.1 China Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.4.4 India
    • 7.4.4.1 India Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
• 7.5 Rest of World
  • 7.5.1 Rest of World Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.5.2 Brazil
    • 7.5.2.1 Brazil Diagnostic Enzymes Market, 2018 - 2030 (USD Million)
  • 7.5.3 South Africa
    • 7.5.3.1 South Africa Diagnostic Enzymes Market, 2018 - 2030 (USD Million)

Chapter 8 Diagnostic Enzymes Market: Competitive Analysis

• 8.1 Recent developments and impact analysis, by key market participants
  • 8.1.1 Ansoff Matrix
  • 8.1.2 Major Deals And Strategic Alliances Analysis
    • 8.1.2.1 Market Expansion
    • 8.1.2.2 Product Launch
    • 8.1.2.3 Acquisition
    • 8.1.2.4 Partnerships and Collaborations
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 List Of Key Distributors And Channel Partners
  • 8.3.2 Key Customers
  • 8.3.3 Key Company Market Share Analysis, 2021
• 8.4 Public Companies
  • 8.4.1 Company Market Position Analysis
  • 8.4.2 Heat Map Analysis
  • 8.4.3 Regional Network Map
  • 8.4.4 Competitive Dashboard Analysis
    • 8.4.4.1 Market Differentiators
• 8.5 Private Companies
  • 8.5.1 List Of Key Emerging Companies
  • 8.5.2 Heat Map Analysis
  • 8.5.3 Regional Network Map

Chapter 9 Company Profiles

• 9.1 Takara Bio, Inc.
  • 9.1.1 Company Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Benchmarking
  • 9.1.4 Strategic Initiatives
• 9.2 Promega Corporation
  • 9.2.1 Company Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Benchmarking
  • 9.2.4 Strategic Initiatives
• 9.3 Enzo Life Sciences, Inc.
  • 9.3.1 Company Overview
  • 9.3.2 Product Benchmarking
• 9.4 Merck KGaA
  • 9.4.1 Company Overview
    • 9.4.1.1 Sigma-Aldrich Co. Llc
  • 9.4.2 Financial Performance
  • 9.4.3 Product Benchmarking
  • 9.4.4 Strategic Initiatives
• 9.5 Thermo Fisher Scientific, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Benchmarking
  • 9.5.4 Strategic Initiatives
• 9.6 Creative Enzymes
  • 9.6.1 Company Overview
  • 9.6.2 Product Benchmarking
• 9.7 F. Hoffmann-La Roche Ltd.
  • 9.7.1 Company Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Benchmarking
  • 9.7.4 Strategic Initiatives
• 9.8 Solis BioDyne
  • 9.8.1 Company Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Benchmarking
• 9.9 Ampliqon A/S
  • 9.9.1 Company Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Benchmarking
  • 9.9.4 Strategic Initiatives